Related Experiment Video
Updated: Aug 31, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Primary anaplastic large cell lymphomas of the pancreas
Ling Chen1, John R Krause1, Haiying Zhang1
1Department of Pathology, Baylor University Medical Center, Dallas, Texas.
Abstract:
Primary pancreatic lymphoma is a rare entity. Primary pancreatic anaplastic large cell lymphoma (ALCL), representing a unique type of primary pancreatic lymphoma, is an extremely rare condition. ALCL is a type of T-cell lymphoma that can be divided into two subtypes based on anaplastic lymphoma kinase (ALK) expression: ALCL-ALK positive, and ALCL-ALK negative. We report two cases of ALCL to represent the unique qualities of these primary pancreatic neoplasms.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management

